The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...

Sarcoidosis remains an enigma in modern medicine. Its hallmark is the formation of noncaseating granulomas, primarily in the lungs, yet the disease extends ...

Immune checkpoint inhibitor therapy for any cancer was associated with a significant reduction of actinic keratoses, ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

Precious metals are not merely ornaments; they are also important components of pharmaceuticals, like the antitumor drug ...